Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Malignant Melanoma

  Free Subscription

Articles published in J Biol Chem

Retrieve available abstracts of 20 articles:
HTML format

Single Articles

    March 2024
  1. LEE YH, Yoon AR, Yun CO, Chung KC, et al
    Dual-specificity kinase DYRK3 phosphorylates p62 at the Thr-269 residue and promotes melanoma progression.
    J Biol Chem. 2024 Mar 20:107206. doi: 10.1016/j.jbc.2024.107206.
    PubMed     Abstract available

    December 2023
  2. GERARD L, Duviver L, Fourrez M, Salazar P, et al
    Identification of two novel heterodimeric ABC transporters in melanoma: ABCB5beta/B6 and ABCB5beta/B9.
    J Biol Chem. 2023 Dec 23:105594. doi: 10.1016/j.jbc.2023.105594.
    PubMed     Abstract available

    November 2023
  3. BAQAI U, Kurimchak AM, Trachtenberg I, Purwin TJ, et al
    Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma.
    J Biol Chem. 2023 Nov 1:105418. doi: 10.1016/j.jbc.2023.105418.
    PubMed     Abstract available

    July 2023
  4. BELANGER F, Roussel C, Sawchyn C, St-Hilaire E, et al
    A genome-wide screen reveals that Dyrk1A kinase promotes nucleotide excision repair by preventing aberrant overexpression of cyclin D1 and p21.
    J Biol Chem. 2023;299:104900.
    PubMed     Abstract available

    June 2023
  5. ZHANG J, Ye ZW, Brautigam L, Chakraborty P, et al
    A Role for Microsomal Glutathione Transferase 1 in Melanin Biosynthesis and Melanoma Progression.
    J Biol Chem. 2023 Jun 13:104920. doi: 10.1016/j.jbc.2023.104920.
    PubMed     Abstract available

    May 2023
  6. TKACIK E, Li K, Gonzalez-Del Pino G, Ha BH, et al
    Structure and RAF family kinase isoform selectivity of type II RAF inhibitors tovorafenib and naporafenib.
    J Biol Chem. 2023;299:104634.
    PubMed     Abstract available

    April 2023
  7. BASU A, Champagne RN, Patel NG, Nicholson ED, et al
    TFCP2 is a transcriptional regulator of heparan sulfate assembly and melanoma cell growth.
    J Biol Chem. 2023 Apr 13:104713. doi: 10.1016/j.jbc.2023.104713.
    PubMed     Abstract available

    March 2023
  8. YACHIDA N, Hoshino F, Murakami C, Ebina M, et al
    Saturated fatty acid- and/or monounsaturated fatty acid-containing phosphatidic acids selectively interact with heat shock protein 27.
    J Biol Chem. 2023;299:103019.
    PubMed     Abstract available

    August 2022
  9. PIETROBONO S, De Paolo R, Mangiameli D, Marranci A, et al
    p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells.
    J Biol Chem. 2022 Aug 6:102353. doi: 10.1016/j.jbc.2022.102353.
    PubMed     Abstract available

    May 2022
  10. MURPHY JM, Jeong K, Erin Ahn EY, Steve Lim ST, et al
    Nuclear focal adhesion kinase induces APC/C activator protein CDH1-mediated cyclin-dependent kinase4/6 degradation and inhibits melanoma proliferation.
    J Biol Chem. 2022 May 4:102013. doi: 10.1016/j.jbc.2022.102013.
    PubMed     Abstract available

    April 2022
  11. ZHANG Q, Haak AJ, Sjogren B
    Regulator of G protein signaling 2 inhibits Galphaq-dependent uveal melanoma cell growth.
    J Biol Chem. 2022 Apr 19:101955. doi: 10.1016/j.jbc.2022.101955.
    PubMed     Abstract available

    December 2021
  12. ONKEN MD, Noda SE, Kaltenbronn KM, Frankfater C, et al
    Oncogenic Gq/11 signaling acutely drives and chronically sustains metabolic reprogramming in uveal melanoma.
    J Biol Chem. 2021 Dec 14:101495. doi: 10.1016/j.jbc.2021.101495.
    PubMed     Abstract available

    September 2021
  13. ANIKEEVA N, Panteleev S, Mazzanti NW, Terai M, et al
    Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs.
    J Biol Chem. 2021;297:101033.
    PubMed     Abstract available

    February 2021
  14. SAYEDYAHOSSEIN S, Huang K, Li Z, Zhang C, et al
    Pannexin 1 binds beta-catenin to modulate melanoma cell growth and metabolism.
    J Biol Chem. 2021 Feb 26:100478. doi: 10.1016/j.jbc.2021.100478.
    PubMed     Abstract available

  15. ONKEN MD, Makepeace CM, Kaltenbronn KM, Choi J, et al
    Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
    J Biol Chem. 2021 Feb 9:100403. doi: 10.1016/j.jbc.2021.100403.
    PubMed     Abstract available

    January 2021
  16. MCANDREWS KM, Che SPY, LeBleu VS, Kalluri R, et al
    Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity.
    J Biol Chem. 2021;296:100523.
    PubMed     Abstract available

  17. HORN IP, Marks DL, Koenig AN, Hogenson TL, et al
    A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition.
    J Biol Chem. 2021;296:100634.
    PubMed     Abstract available

    December 2020
  18. CERAUDO E, Horioka M, Mattheisen JM, Hitchman TD, et al
    Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active with highly biased signaling.
    J Biol Chem. 2020 Dec 6. pii: RA120.015352. doi: 10.1074/jbc.RA120.015352.
    PubMed     Abstract available

    August 2020
  19. KOZLOV G, Funato Y, Chen YS, Zhang Z, et al
    PRL3 pseudophosphatase activity is necessary and sufficient to promote metastatic growth.
    J Biol Chem. 2020;295:11682-11692.
    PubMed     Abstract available

    March 2020
  20. GROLLA AA, Miggiano R, Di Marino D, Bianchi M, et al
    A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD(+) salvage pathway in the nucleus.
    J Biol Chem. 2020;295:3635-3651.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.